≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Carcinoma in situ of rectosigmoid junction

Endpoint Browser

CD2_INSITU_RECTOSIGMOID_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D01.1&
  • Cause of death: ICD-10 — D01.1&

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D01
Name in latin
Carcinoma in situ junctionis rectosigmoideae

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 10 6 -
Unadjusted period prevalence (%) 0.00 0.00 -
Median age at first event (years) 63.98 59.64 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
5
15
5.54
1.77
4.4
3.6
—
—
—
0
0
5
19
4.19
1.41
2.8
2.5
14.5
16.5
mg/l
—
5
13
5
19
4.19
1.41
4.0
7.1
—
—
—
0
0
5
32
2.11
0.52
7.8
2.5
—
—
—
0
0
5
37
1.69
0.30
8.0
2.3
—
0.0
—
0
6
5
63
0.59
0.30
3.8
4.0
1.2
1.2
mmol/l
—
5
58
5
40
1.49
0.13
8.0
2.4
—
0.0
—
0
6
0
5
0.00
0.00
0.0
8.4
—
25.9
—
0
5
0
5
0.00
0.00
0.0
14.2
—
25.4
—
0
5
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
0
5
0.00
0.00
0.0
13.4
—
109.2
—
0
5
0
6
0.00
0.00
0.0
22.7
—
—
—
0
0
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
0
6
0.00
0.00
0.0
11.5
—
93.3
—
0
6
0
7
0.00
0.00
0.0
13.0
—
12.2
—
0
7
0
7
0.00
0.00
0.0
11.6
—
1.0
—
0
7
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.0
—
352.3
—
0
8
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_RECTOSIGMOID_EXALLC – Carcinoma in situ of rectosigmoid junction

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).